RLMD Earnings & Financial Statements
Relmada Therapeutics, Inc.
$3.27
-$0.02(-0.61%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
1.10M
52W Range
$1.97 - $8.00
Target Price
--
RLMD earnings and financial statements: Relmada Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLMD | $3.27 | -0.6% | 1.10M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Relmada Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW